Keeping Hearts Beating
Rambam’s distinction as a world-leader in cardiovascular medicine rests upon decades of innovations developed by its gifted researchers, including minimally-invasive treatment approaches, sophisticated 3D imaging systems to visualize the heart during surgery, and pioneering work with cardiac stem cells.
The new Eyal Ofer Heart Hospital will enable Rambam to leverage its formidable expertise in research and cardiovascular disease treatment to address the foremost cause of mortality in the western world.
The Eyal Ofer Heart Hospital, now under construction, will support the most modern facilities available under one roof for treatment, surgery, imaging, intensive care, research and preventive care. And as the focal point for Rambam’s extraordinary expertise and innovations in the field, it will become a launching stage for the development of new diagnostic and therapeutic approaches.
Naming opportunities are available for entire floors, departments, units, and medical equipment. If advancing cardiovascular medicine and research is a cause that is close to your heart, there are many ways you can make an impact.
Please contact Canadian Friends of Rambam for more information at (416) 481-5552.
Ending Sudden Cardiac Death (SCD) in Children and Young Adults
Professor Lior Gepstein, Director of Cardiology at Rambam and a Technion researcher, made medical history when he differentiated embryonic stem cells into functioning heart cells in vitro. Now Dr. Oren Caspi, an intern in Rambam’s Department of Cardiology, is using his mentor’s system to transform induced pluripotent stem cells into heart cells that encapsulate the factors causing Sudden Cardiac Death Syndrome–a leading cause of death in young people. Dr. Caspi’s research could potentially lead to new diagnostic and treatment approaches for this devastating condition.